$26.77
2.92% yesterday
Nasdaq, Nov 25, 10:01 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Stock price

$26.77
+4.74 21.52% 1M
+5.05 23.25% 6M
+10.52 64.74% YTD
+13.33 99.18% 1Y
-17.18 39.09% 3Y
+10.12 60.78% 5Y
+24.53 1,095.09% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.76 2.92%
ISIN
US09062W2044
Symbol
BLFS
Sector

Key metrics

Market capitalization $1.24b
Enterprise Value $1.25b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 220.65
EV/Sales (TTM) EV/Sales 10.11
P/S ratio (TTM) P/S ratio 10.07
P/B ratio (TTM) P/B ratio 3.80
Revenue growth (TTM) Revenue growth -20.31%
Revenue (TTM) Revenue $123.36m
EBIT (operating result TTM) EBIT $-27.82m
Free Cash Flow (TTM) Free Cash Flow $5.65m
Cash position $34.37m
EPS (TTM) EPS $-0.82
P/E forward negative
P/S forward 11.15
EV/Sales forward 11.19
Short interest 11.24%
Show more

Is BioLife Solutions, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

BioLife Solutions, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BioLife Solutions, Inc. forecast:

10x Buy
100%

Analyst Opinions

10 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
100%

Financial data from BioLife Solutions, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
123 123
20% 20%
100%
- Direct Costs 74 74
32% 32%
60%
49 49
8% 8%
40%
- Selling and Administrative Expenses 55 55
15% 15%
45%
- Research and Development Expense 12 12
33% 33%
10%
-18 -18
52% 52%
-15%
- Depreciation and Amortization 9.39 9.39
42% 42%
8%
EBIT (Operating Income) EBIT -28 -28
49% 49%
-23%
Net Profit -37 -37
64% 64%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about BioLife Solutions, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioLife Solutions, Inc. Stock News

Neutral
PRNewsWire
12 days ago
Completes the Company's strategic move away from capital equipment businesses BOTHELL, Wash. , Nov. 14, 2024 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the sale of its final wholly owned freezer subsidiary, Arctic Solutions, Inc. ...
Neutral
Seeking Alpha
13 days ago
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Rod de Greef - Chairman and Chief Executive Officer Garrie Richardson - Chief Revenue Officer Conference Call Participants Matt Stanton - Jefferies Brendan Smith - TD Cowen Anna Snopkowski - KeyBanc Matt Hewitt - Craig-Hallum Capital...
Neutral
PRNewsWire
14 days ago
Cell Processing revenue grew 6%  sequentially to $19.0 million; 43% increase compared to 2023 GAAP gross margin of 51%  and non-GAAP adjusted gross margin of 54% GAAP net loss from continuing operations of $1.7 million and non-GAAP adjusted EBITDA of $6.1 million or 20% Increasing Cell Processing revenue guidance by $2 million to $72.0 to $73.0 million; total 2024 revenue guidance of $98.0 mill...
More BioLife Solutions, Inc. News

Company Profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 414
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today